{
  "Q0": "BRCA1/BRCA2 genetic testing for hereditary breast and ovarian cancer risk assessment",
  "Q1": "No",
  "Q2": "No",
  "Q3": "No",
  "Q4": "No",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "No",
  "Q9": "Yes",
  "Q9_follow_up": "No",
  "Q10": "No",
  "Q10_follow_up": "Risk Assessment",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "According to the policy, prior authorization is required for BRCA1/BRCA2 testing. The request must include documentation of clinical risk factors that meet the policy criteria. For this patient, since the criteria are not met, the test would not be approved. If the provider still wishes to pursue testing, they would need to document medical necessity with additional risk factors or obtain a referral to a genetics professional who could evaluate the patient according to recognized guidelines."
}